The Morning Science

What science found today

‹
 

Topic

Egfr

3 stories about Egfr that passed the news check, newest first.

  1. Research ·

    Joint latent class mixed model trajectories of estimated glomerular filtration rate related to mortality and physical activity in older adults

    A nature.com article describes joint latent class mixed model trajectories of estimated glomerular filtration rate.

    Medical research : nature.com subject feeds

  2. Launch ·

    FDA approves amivantamab-vmjw with carboplatin and pemetrexed for non-small cell lung cancer with EGFR exon 19 deletions or L858R mutations

    On September 19, 2024, the FDA approved amivantamab-vmjw (Rybrevant, Janssen Biotech) with carboplatin and pemetrexed.

    What's New: Drugs RSS Feed

  3. Policy ·

    FDA approves amivantamab-vmjw for EGFR exon 20 insertion-mutated non-small cell lung cancer indications

    The FDA approved amivantamab-vmjw (Rybrevant, Janssen Biotech) with carboplatin and pemetrexed.

    What's New: Drugs RSS Feed